Literature DB >> 19385588

Osteoporosis: management and densitometry for orthopaedic surgeons.

Laura M B Gehrig1, Cory Collinge, John Kaufman, Joseph M Lane, Mary I O'Connor, Laura L Tosi.   

Abstract

Osteoporosis is a metabolic condition that is increasing in prevalence as people live longer. A fracture is a sentinel event. Despite all the advances in technology, a history of low-energy fracture in adulthood is the best predictor of future fracture-an even better predictor than low bone mineral density. Osteoporosis and the risk of fracture go hand in hand. The orthopaedic surgeon is often viewed as an expert in managing and treating bone disorders. Given that the orthopaedic surgeon is often the first and only physician to evaluate a patient with a fracture, he or she may be in the ideal position to initiate patient evaluation and therapy. However, many times the orthopaedic surgeon is concerned about the adverse effects of the pharmacologic treatment of osteoporosis to the extent that prescribing these drugs is avoided. A treatment approach incorporating nonpharmacologic agents is an effective strategy in the prevention and treatment of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19385588

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  1 in total

1.  Comparison of parameters of bone profile and homocysteine in physically active and non-active postmenopausal females.

Authors:  Sundus Tariq; Khalid Parvez Lone; Saba Tariq
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.